GO:0034235 GPI anchor binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0034235 (GPI anchor binding) is a molecular function defined as binding to a glycosylphosphatidylinositol anchor, the glycolipid that attaches proteins to the cell membrane.
• GPI-anchored proteins are synthesized in the endoplasmic reticulum and remodeled in the Golgi before reaching the plasma membrane, where they mediate adhesion, signaling, and enzymatic activities.
• Key proteins involved in GPI anchor binding include T-cadherin (CDH13), prion protein (PRNP), and Ly6/uPAR family members, which interact with GPI anchors or GPI-anchored proteins.
• Dysregulation of GPI anchor binding is linked to congenital disorders of glycosylation (PMM2-CDG), neurodegeneration, and cancer.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable precise interrogation of GPI anchor binding in disease contexts.
• EDITGENE provides end-to-end CRISPR services, including library screening and bioinformatics, to accelerate GPI anchor binding research.
Description
GPI anchor binding (GO:0034235) is a molecular function that enables a protein to selectively interact with glycosylphosphatidylinositol (GPI) anchors, the complex glycolipids that tether many cell-surface proteins to the membrane. This binding activity is fundamental to the assembly, trafficking, and function of GPI-anchored proteins, which lack transmembrane domains and instead rely on a C-terminal GPI anchor for membrane attachment. Researchers study GPI anchor binding to understand how cells organize their surface proteome, how signals are transduced across the membrane, and how defects in this process contribute to human disease. The importance of GPI anchor binding extends beyond basic cell biology. GPI-anchored proteins participate in diverse processes such as cell adhesion, immune recognition, and neuronal development. Mutations in genes required for GPI anchor biosynthesis cause inherited disorders like PMM2-CDG, where abnormal GPI-anchored protein expression is observed. Moreover, pathogens and toxins exploit GPI anchors for host cell entry, and cancer cells often alter GPI-anchored protein profiles to promote invasion and metastasis. Thus, understanding the molecular details of GPI anchor binding offers insights into both normal physiology and disease mechanisms.
GPI anchor binding At A Glance
| GO ID | GO:0034235 |
|---|---|
| GO term | GPI anchor binding |
| Ontology | molecular_function |
| Synonym | glycosylphosphatidylinositol binding |
| Major function | Binding to glycosylphosphatidylinositol anchors, mediating protein-membrane and protein-protein interactions |
| Definition source | QuickGO |
| Related proteins | T-cadherin (CDH13), prion protein (PRNP), Ly6/uPAR family members |
| Disease relevance | Congenital disorders of glycosylation, neurodegeneration, cancer |
What Is GO:0034235?
GO:0034235 (GPI anchor binding) is defined as the binding to a glycosylphosphatidylinositol anchor. GPI anchors serve to attach membrane proteins to the lipid bilayer of cell membranes. This molecular function is synonymous with glycosylphosphatidylinositol binding and is essential for the interaction of proteins with GPI-anchored partners or with the GPI moiety itself.
Why Is GPI anchor binding Important in Cell Biology?
GPI anchor binding is critical for the correct localization and function of numerous cell-surface proteins. It influences cell signaling, adhesion, and immune responses, and its disruption is associated with developmental defects and diseases such as PMM2-CDG and prion disorders. Studying this function helps elucidate mechanisms of protein sorting and membrane dynamics, and it provides targets for therapeutic intervention.
• GPI anchor binding enables membrane attachment of proteins lacking transmembrane domains.
• It is essential for the function of GPI-anchored proteins in cell adhesion and signaling.
• Defects in GPI anchor metabolism lead to congenital disorders of glycosylation like PMM2-CDG.
• GPI anchor binding is implicated in neurodegenerative diseases, including prion diseases.
• Cancer cells often exhibit altered GPI-anchored protein expression, affecting invasion and metastasis.
• It plays a role in host-pathogen interactions, as some pathogens bind GPI anchors.
• Understanding GPI anchor binding aids in the development of targeted therapeutics.
• It is a key area for CRISPR-based functional genomics and drug discovery.
Molecular Mechanism of GPI anchor binding
GPI Anchor Structure and Recognition
In simple terms: The GPI anchor is a glycolipid that acts like a molecular hook, and proteins that bind it have specific pockets that recognize its sugar and lipid parts.
GPI anchors consist of a phosphatidylinositol lipid, a glycan core, and a phosphoethanolamine linker that attaches to the protein's C-terminus. Proteins that bind GPI anchors, such as T-cadherin, interact with the glycan or lipid moieties, facilitating cell adhesion and signaling. The structural diversity of GPI anchors across species influences binding specificity.
Binding to GPI-Anchored Proteins
In simple terms: Some proteins bind not just the GPI anchor but also the protein part, forming a complex that can transmit signals.
T-cadherin (CDH13) binds to adiponectin via its extracellular cadherin repeats, and this interaction requires the unique prodomain and GPI anchor. The 130 kDa cell surface LDL-binding protein was identified as a partially processed T-cadherin precursor, highlighting the role of GPI anchor binding in lipoprotein metabolism.
Regulation by ER Stress and Glycosylation
In simple terms: Cellular stress can disrupt the production of GPI anchors, leading to abnormal proteins that may be recognized by binding partners.
Persistent ER stress causes GPI anchor deficit, converting a GPI-anchored prion protein into pro-PrP via the ATF6-miR449c-5p-PIGV axis. This illustrates how GPI anchor binding is regulated by ER homeostasis and glycosylation pathways.
Orientational Preferences and Membrane Dynamics
In simple terms: GPI-anchored proteins can tilt and move within the membrane, and binding partners may influence their orientation.
Ly6/uPAR proteins exhibit orientational preferences when GPI-anchored, affecting their interaction with ligands and receptors. Such dynamics are crucial for signal transduction and cell-cell communication.
Key Genes Involved in GO:0034235 GPI anchor binding
The following genes and proteins are directly involved in GPI anchor binding or are GPI-anchored themselves, serving as key research targets.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CDH13 (T-cadherin) | GPI-anchored cadherin that binds adiponectin and LDL | Adiponectin signaling, cancer, cardiovascular disease |
| PRNP (Prion protein) | GPI-anchored protein involved in neurodegeneration | Prion diseases, ER stress, GPI anchor deficit |
| LY6/uPAR family | GPI-anchored proteins with diverse functions | Immune regulation, cancer, orientational preferences |
| PIGV | GPI mannosyltransferase, involved in GPI anchor biosynthesis | Regulated by miR449c-5p under ER stress |
| PMM2 | Phosphomannomutase 2, required for GPI anchor synthesis | PMM2-CDG, congenital disorder of glycosylation |
| GPAA1 | GPI transamidase component | GPI anchor attachment, structure of human GPI transamidase |
| PIGK | GPI transamidase catalytic subunit | GPI anchor attachment |
| PIGS | GPI transamidase component | GPI anchor attachment |
| PIGT | GPI transamidase component | GPI anchor attachment |
| PIGU | GPI transamidase component | GPI anchor attachment |
| ADIPOR1/2 | Adiponectin receptors | Adiponectin signaling, T-cadherin interaction |
| GPI-anchored fungal adhesins | Mediate adhesion in fungi | Diversity of GPI-anchored adhesins |
| LDL receptor | Binds LDL, related to T-cadherin precursor | Lipoprotein metabolism |
| ATF6 | ER stress transcription factor | Regulates PIGV via miR449c-5p |
| miR449c-5p | MicroRNA targeting PIGV | ER stress response |
| GPI-anchored proteins (general) | Cell surface attachment | Basic cell biology and disease |
How Is GPI anchor binding Regulated?
GPI anchor binding is regulated at multiple levels. ER stress induces the ATF6-miR449c-5p-PIGV axis, reducing GPI anchor biosynthesis and altering the binding of GPI-anchored proteins. Glycosylation disorders such as PMM2-CDG affect the expression of GPI-anchored proteins, indirectly influencing binding interactions. Additionally, the lipid composition of the membrane and the presence of binding partners like adiponectin can modulate T-cadherin's GPI anchor binding.
GPI anchor binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PMM2 | PMM2-CDG (congenital disorder of glycosylation) | Patient-derived fibroblasts, CRISPR knock-in of patient mutations |
| PRNP | Prion diseases, ER stress | Knockout and point mutation in neuronal cell lines |
| CDH13 | Cancer, cardiovascular disease | Overexpression and knockout in cancer cell lines |
| PIGV | GPI anchor biosynthesis defects | CRISPR knockout in HEK293T, ER stress induction |
| GPAA1 | GPI transamidase deficiency | Knockout in cell lines, rescue with wild-type |
Congenital Disorders of Glycosylation
PMM2-CDG patients exhibit abnormal GPI-anchor and GPI-anchored protein expression, leading to multi-systemic symptoms. This highlights the importance of GPI anchor binding in development.
Neurodegeneration
In prion diseases, ER stress causes GPI anchor deficit, converting normal prion protein into pro-PrP, which may contribute to neurotoxicity. GPI anchor binding is thus linked to protein misfolding disorders.
Cancer
T-cadherin (CDH13) is a GPI-anchored protein that binds adiponectin; its expression is often altered in cancer, affecting cell proliferation and migration. GPI anchor binding may influence tumor progression.
From GPI anchor binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of GPI anchor binding affect cell adhesion? | CRISPR knockout of CDH13 in epithelial cells |
| How do point mutations in PRNP alter GPI anchor binding? | Point mutation knock-in in neuronal cells |
| Can overexpression of T-cadherin enhance adiponectin signaling? | Overexpression in adipocytes or endothelial cells |
| What is the role of PIGV in ER stress-induced GPI anchor deficit? | Knockout and rescue with miR449c-5p inhibitor |
| Does GPI anchor binding regulate immune recognition? | Knockout of Ly6/uPAR genes in immune cells |
| Can tagged GPI-anchored proteins be used for imaging? | Knock-in of fluorescent tags in GPI-anchored genes |
How to Study the GPI anchor binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| ELISA | Binding affinity between GPI anchors and proteins | Quantify T-cadherin-adiponectin interaction |
| Surface plasmon resonance | Real-time binding kinetics | Measure GPI anchor binding affinity |
| Mass spectrometry | Protein identification and glycan structure | Characterize GPI-anchored proteome |
| Flow cytometry | Cell surface expression of GPI-anchored proteins | Assess PMM2-CDG patient cells |
| Fluorescence microscopy | Subcellular localization | Visualize GPI-anchored proteins in membranes |
| CRISPR knockout screening | Gene essentiality for GPI anchor binding | Identify novel regulators |
| RNA-seq | Transcriptional changes | Measure ER stress response genes |
| Western blot | Protein expression and processing | Detect pro-PrP conversion |
Biochemical Binding Assays
Enzyme-linked immunosorbent assays (ELISA) and surface plasmon resonance (SPR) can measure direct binding between GPI anchors and candidate proteins.
Proteomics and Glycomics
Mass spectrometry-based proteomics identifies GPI-anchored proteins and their binding partners, while glycomics characterizes GPI anchor structures.
Imaging and Flow Cytometry
Fluorescence microscopy and flow cytometry using GPI-anchored protein-specific antibodies or fluorescent tags reveal localization and binding dynamics.
CRISPR Screening
Genome-wide CRISPR knockout screens can identify genes required for GPI anchor binding and function, followed by bioinformatics analysis.
How CRISPR Can Be Used to Study GO:0034235 GPI anchor binding
Knockout
CRISPR knockout of genes like CDH13, PRNP, or PIGV eliminates GPI anchor binding, enabling loss-of-function studies in cell models.
Point Mutation
Introducing disease-associated point mutations (e.g., in PMM2 or PRNP) via CRISPR base editing or HDR allows precise modeling of GPI anchor binding defects.
Knock-in
Knock-in of fluorescent or affinity tags into GPI-anchored genes facilitates tracking and purification of GPI anchor binding complexes.
Overexpression
CRISPR activation or cDNA overexpression of T-cadherin or other GPI-anchored proteins boosts GPI anchor binding, useful for gain-of-function studies.
How EDITGENE Supports GPI anchor binding Research
Researchers studying GPI anchor binding-related genes often need to determine whether a candidate gene is causally involved in GPI anchor binding, and to dissect the molecular consequences of specific mutations. EDITGENE provides tailored CRISPR solutions to address these questions with precision and scale.
Contact EDITGENE today to design your custom CRISPR model for GPI anchor binding research.
Frequently Asked Questions About GPI anchor binding
What is GPI anchor binding?
GPI anchor binding is a molecular function (GO:0034235) where a protein binds to a glycosylphosphatidylinositol anchor, a glycolipid that attaches proteins to cell membranes.
What genes are involved in GPI anchor binding?
Key genes include CDH13 (T-cadherin), PRNP (prion protein), PIGV, PMM2, and GPAA1, among others.
How is GPI anchor binding related to disease?
Defects in GPI anchor binding are linked to PMM2-CDG, prion diseases, and cancer.
What is the function of GPI anchors?
GPI anchors attach proteins to the lipid bilayer, allowing them to be displayed on the cell surface.
Can CRISPR be used to study GPI anchor binding?
Yes, CRISPR knockout, knock-in, and point mutation models are powerful tools to study GPI anchor binding.
What are GPI-anchored proteins?
GPI-anchored proteins are proteins attached to the membrane via a GPI anchor, lacking transmembrane domains.
How does ER stress affect GPI anchor binding?
ER stress can reduce GPI anchor biosynthesis via the ATF6-miR449c-5p-PIGV axis, altering GPI anchor binding.
What is the role of T-cadherin in GPI anchor binding?
T-cadherin is a GPI-anchored protein that binds adiponectin and LDL, and its GPI anchor is essential for these interactions.
Which diseases are associated with PMM2 mutations?
PMM2 mutations cause PMM2-CDG, a congenital disorder of glycosylation with abnormal GPI-anchored protein expression.
How can I model GPI anchor binding defects in the lab?
Use CRISPR to knockout or mutate genes like PMM2, PRNP, or PIGV in cell lines, then assess GPI anchor binding by ELISA or flow cytometry.
Conclusion
GPI anchor binding (GO:0034235) is a fundamental molecular function that governs the membrane attachment and function of a diverse array of cell-surface proteins. Its roles in health and disease, from congenital glycosylation disorders to neurodegeneration and cancer, make it a compelling research focus. Leveraging CRISPR-based models and EDITGENE's services can accelerate discoveries in this field.
References
- 1. Ikezawa H. 2002. Glycosylphosphatidylinositol (GPI)-anchored proteins.. Biol Pharm Bull 25(4):409-17 PMID: 11995915
- 2. Essen LO et al.. 2020. Diversity of GPI-anchored fungal adhesins.. Biol Chem 401(12):1389-1405 PMID: 33035180
- 3. Fukuda S et al.. 2017. The unique prodomain of T-cadherin plays a key role in adiponectin binding with the essential extracellular cadherin repeats 1 and 2.. J Biol Chem 292(19):7840-7849 PMID: 28325833
- 4. Zhang H et al.. 2022. Structure of human glycosylphosphatidylinositol transamidase.. Nat Struct Mol Biol 29(3):203-209 PMID: 35165458
- 5. Stambolsky DV et al.. 1999. Identification of 130 kDa cell surface LDL-binding protein from smooth muscle cells as a partially processed T-cadherin precursor.. Biochim Biophys Acta 1416(1-2):155-60 PMID: 9889357
- 6. Li J et al.. 2023. Persistent ER stress causes GPI anchor deficit to convert a GPI-anchored prion protein into pro-PrP via the ATF6-miR449c-5p-PIGV axis.. J Biol Chem 299(8):104982 PMID: 37390992
- 7. de la Morena-Barrio ME et al.. 2013. GPI-anchor and GPI-anchored protein expression in PMM2-CDG patients.. Orphanet J Rare Dis 8:170 PMID: 24139637
- 8. Zaigraev MM et al.. 2022. Orientational Preferences of GPI-Anchored Ly6/uPAR Proteins.. Int J Mol Sci 24(1) PMID: 36613456
